Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
AXON$422.00+7.40(+1.78%)Axon Announces Body 5: Next-Generation Camera Built for the AI Era Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more...[1:00:00 PM ET]PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]
News desk

Live news

Stock news, press releases, and legal notices, with ticker, type, source, and time. Signed-out visitors and Free accounts see the last year, 15 minutes behind. Pro, including the 7-day trial, sees the full archive as each headline is ingested.

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
ETH Stock news Ethereum ETFs Have Lost $1.1 Billion in Three Weeks. What Would Bring Buyers Back? 24/7 Wall Street
NFLX Stock news Down Roughly 50% From Its Highs, Is Netflix Stock Finally a Buy? The Motley Fool
CBRE Stock news CBRE: 3 Key Takeaways for Long-Term Investors The Motley Fool
YRD Legal Rosen Law Firm Encourages Yiren Digital Ltd. Investors to Inquire About Securities Class Action Investigation - YRD Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Yiren... PR Newswire
NKE Stock news Is Nike Still a Growth Stock? Here's the Answer. The Motley Fool
MU Stock news Wall Street analyst issues new bullish Micron stock price target Finbold
AVGOP Stock news Broadcom vs. Dell Technologies: Which Stock Is AI Powering to Be a Better Buy in 2026? The Motley Fool
ABNB Stock news Airbnb vs. Chewy: Do Pets or Places Power One Stock More than the Other? The Motley Fool
BE Stock news Bloom Energy Raised Its 2026 Forecast for the Third Time. Is the Stock a Buy More Than a Third Below Its Record? The Motley Fool
AAPL Stock news Apple Joins Nvidia in the $5 Trillion Club. Here's Which Stock I Think Can Get to $10 Trillion First. The Motley Fool
UNH Stock news Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy? The Motley Fool
HON Stock news Honeywell Technologies: 3 Key Takeaways for Long-Term Investors The Motley Fool
P-OPEA Stock news FBI Explores Espionage Case Against Saudi OpenAI Suspect WSJ
APPN Stock news Why Appian Stock Surged 24.2% This Week The Motley Fool
CNFR Stock news Conifer Management Buys $16.9 Million Group 1 Automotive Shares. What Does This Mean for Investors? The Motley Fool
BUDA Stock news BUDA Details Ultra Fresh Expansion, New Plants and Wholesale Growth Strategy MarketBeat
AMT Stock news 4 Data Center REITs With Growing Dividends and an AI Tailwind 24/7 Wall Street
Stock news Here's What the Average Social Security Benefit Actually Covers Fool - Investing News
AXON Press release Axon Announces Body 5: Next-Generation Camera Built for the AI Era Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more... PR Newswire
MSFT Stock news Exit interview: Microsoft's comms chief on CEOs, reporters, what he got wrong, and stories that stuck GeekWire
Market Pulse

The same desk, in your inbox.

Market Pulse picks three headlines from the day, names the stock that moved, and shows the call that returns each one.

Monday, Wednesday, and Friday. Unsubscribe from any issue, or from account settings if you have one.

FAQ

Frequently asked questions

Is the live news desk the same feed as the API?
The desk shows the same articles in the browser: ticker, type, source, and published time. Signed-out visitors and Free accounts see the last year, 15 minutes behind. Pro, including the 7-day trial, sees the full archive as soon as a row is ingested. A Free API key returns the last year. Pro keys search the full archive and also include the summary and the original URL.
Why is the live news desk delayed?
Signed-out visitors and Free accounts see this desk 15 minutes behind ingestion, across the last year of headlines. Pro, including the 7-day trial, sees the full archive as soon as headlines are ingested. A Free API key has the same 15-minute delay. The delay is the plan, not an outage, and the status page stays green while the delayed view is on.
How far back does the live news desk go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices, 15 minutes behind ingestion. Pro, including the 7-day trial, sees the full archive as new rows are ingested. Page size is 20. A Free API key returns the last year. Pro keys search the full archive.
How do I see stock news without the 15-minute delay?
Start the 7-day Pro trial and sign in. A card is required. Pro is $15 a month, or $162 a year, and this desk then shows the full archive as headlines are ingested. Signed-out visitors and Free accounts still see the last year of headlines 15 minutes behind. A Free API key stays at 100 requests a day, the same delay, and the last year. One trial per email.
What do the columns on the news desk mean?
Ticker is the symbol attached to the article. Type is stock news, press release, or legal. Headline is the title. Source is the publisher or wire. Published is the article time in Eastern Time. Page size is 20. Use the type buttons when you want wires only, or legal notices kept out of the list.
Can I search the live news desk by ticker?
Yes. The desk has a ticker search, a headline search, a source menu, and buttons for stock news, press releases, and legal notices. Those filters stay on this page. The same filters exist on GET /v1/news if you want the JSON, including the summary and the original URL. Page size on the desk is 20.
How often do new stock headlines appear?
Sources are polled every second, including nights and weekends. Pro, including the 7-day trial, sees a row as soon as it is ingested. Signed-out visitors and Free accounts see that same row 15 minutes later. The desk is a browser view of the API feed, not a second dataset.